Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Beta This is a new resource - your feedback will help us improve it.

Nationwide Analysis of Antipsychotic Drug Use in Nursing Homes

Announced on  | Last Modified on  | Project Number: OEI-02-23-00202
Status
Active
Agency
Centers for Medicare and Medicaid Services

OBJECTIVE

The overuse of antipsychotic drugs presents a risk to nursing home residents, particularly those with dementia.  These drugs are not approved to treat dementia, and the Food and Drug Administration has warned that they may increase the risk of death for these individuals.  OIG has longstanding concerns about the overuse of these drugs in nursing homes.  OIG’s recent review of nursing home inspections found that nursing homes gave antipsychotic drugs to residents to manage their behavior for the benefit of staff.  We will conduct a nationwide analysis to determine the extent of antipsychotic drug use among Medicare beneficiaries in nursing homes, including the extent to which those beneficiaries had a dementia diagnosis.

TIMELINE

  • June 29, 2026
    Announced
Work Plan Type
Office of Evaluation and Inspections
HHS Agencies
Centers for Medicare and Medicaid Services
Issue Areas
Nursing Homes, Nursing Facilities, and Assisted Living Facilities Quality of Care
Target Groups
Elderly
Financial Groups
Medicare A